Atypical Antipsychotics and Neuroleptic Malignant Syndrome: Dear Editor

Biancosino B Zanchi P Agostini M Grassi L. Suspected neuroleptic catatonia induced by clozapine. Can J Psychiatry 2001;46:5:458.

Philbrick KL Rummans TA . Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994;6:1–13.

Sachdev P Kruk J Kneebone M Kissane D. Clozapine-induced neuroleptic malignant syndrome: Review and report of new cases. J Clin Psychopharmacol 1995;15:365–71.

Hasan S Buckley P. Novel antipsychotics and the neuroleptic malignant: A review and critique. Am J Psychiatry 1998;155:1113–6.

Caroff SN Mann SC Campbell EC . Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann 2000;30:314–21.

Nitenson NC Kando JC Frankenburg FR Zanarini MC . Fever associated with clozapine administration. Am J Psychiatry 1995;152:1102.

Bush G Fink M Petrides G Dowling F Francis A. Catatonia: II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137–43.

Francis A Chadragiri S Rizvi S. Lorazepam therapy of the neuroleptic malignant syndrome. Paper presented at the Annual Meeting of the American Psychiatric Association; May 30–June 4, 1998; Toronto (ON).

Fricchione G Bush G Fozdar M Francis A Fink M. The recognition and treatment of the catatonic syndrome. J Intensive Care Med 1997;12:135–47.

Kapur S Zipursky RB Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 1999;156:286–93.